Ambroxol Tablets, Sustained-Release Capsules and Combination Medicines
Read the complete ingredient list and release form when checking a mucus-relief medicine.
Reference table
Ambroxol reference table
The catalogue includes ambroxol 30 mg tablets and 75 mg sustained-release capsules. It also includes products combining ambroxol with other medicines. Read the full formulation before comparing a strength or requesting a quotation.
Single ingredient and combination presentations
| Presentation | Label information | What to confirm |
|---|---|---|
| Ambroxol 30 mg tablet | Amount per tablet | Exact manufacturer and local leaflet |
| Ambroxol 75 mg SR capsule | Strength and sustained-release wording | Capsule instructions and prescribed schedule |
| Combination medicine | Every ingredient and strength | Purpose and precautions of each component |
| Liquid product, where prescribed | Concentration per stated volume | Age-specific product and measuring instructions |
The source product and country are identified in the article. Confirm personal treatment instructions with the prescribing clinician.
What ambroxol information can establish
Ambroxol is used in medicines intended to assist mucus clearance in respiratory conditions. The European Medicines Agency's safety review covers ambroxol- and bromhexine-containing expectorants marketed in participating countries. The precise indication and age range should be read from the local product leaflet.
The cause of a cough matters. A mucus-relief product cannot by itself establish whether an infection, asthma, another lung condition or a non-respiratory cause needs treatment. A clinician or pharmacist should assess persistent symptoms and check whether the actual preparation is appropriate.
Single ingredient and combination presentations
The catalogue includes ambroxol 30 mg tablets and 75 mg sustained-release capsules. It also includes products combining ambroxol with other medicines. Read the full formulation before comparing a strength or requesting a quotation.
The table supports product identification. It provides no conversion between ordinary and sustained-release products.
Dosing and administration questions
Use the prescribed product's instructions for timing, course and administration. Release wording such as SR is part of the formulation. Ask a pharmacist before opening, crushing or changing a modified-release product.
Children need a product and schedule appropriate to their age and the local label. Adult tablet or capsule strengths do not establish a child's regimen. Where a liquid has been prescribed, record the concentration and use the specified measuring device. A millilitre quantity has meaning only when the liquid strength is known.
Skin reactions and concerning symptoms
EMA recommends that ambroxol and bromhexine information include warnings about allergic reactions and serious skin reactions. Stop the medicine and seek medical advice if a rash develops, particularly with sores affecting the mouth or other mucosal surfaces. Swelling of the face or throat or breathing difficulty requires urgent care.
Severe breathlessness, chest pain, coughing blood, worsening illness or persistent fever needs medical assessment. Report the complete medicine list and relevant medical conditions so the clinician can evaluate the symptoms and the product together. Avoid relying on a symptom-relief response as proof that the underlying condition is resolved.
Preparing an exact product enquiry
State whether the request is for ambroxol alone or a combination. Include each strength, tablet or capsule form, SR wording where relevant, brand and manufacturer preference, quantity and destination. Ask for the actual product leaflet and pack image if a release form is unclear.
A receiving pharmacy or importer should confirm the applicable product status and requirements. Export documentation and availability depend on the precise formulation and order. Public enquiries can contain the product specification and organisational contact details while individual treatment histories remain with the clinical team.
Product information for an enquiry
View Ambroxol 30 mg Tablets, Ambroxol 75 mg SR Capsules for the listed formulations. Include the exact strength, dosage form, quantity and destination in a professional product enquiry.
Export product support
Need product, pack, and documentation details?
Global Medicines Export can support international B2B enquiries for product availability, strengths, pack information, quotation coordination, and shipment documentation review.
Common questions
Are 30 mg tablets and 75 mg SR capsules directly interchangeable?
They have different strengths and release descriptions. The prescription and exact product information should determine which preparation is supplied.
Does ambroxol treat every cough?
Coughs have different causes. The actual product's indication and a clinical assessment determine whether it is appropriate.
Why check every ingredient in a combination?
A second ingredient adds its own purpose, precautions and interaction questions. The ambroxol amount describes only one component.
Which rash symptoms should be reported?
Stop the medicine and obtain advice for a new rash, especially with mouth or other mucosal sores. Serious allergy or breathing difficulty requires urgent care.
Important medical note
This article is for general educational information only. It is not medical advice, diagnosis, or a treatment plan. Medicines should be used only under the guidance of a qualified healthcare professional. Product availability, export documentation, and quotation support do not imply that a medicine is appropriate for any individual patient.